Skip to main content
. 2009 Aug 1;2:8. doi: 10.1186/1756-6614-2-8

Figure 2.

Figure 2

Serum thyroglobulin changes during 13-cis-retinoic acid therapy and after administration of recombinant human thyroid-stimulating hormone therapy, 0.9 mg/day × 2. Only patients (n = 41) showing no interference from anti-thyroglobulin antibodies, based on thyroglobulin recovery >70% were included. Hollow squares indicate the median value, while t bars indicate the 25% and 75% percentile. X-axis time scale is not exact.